ParaPro offers Natroba for new indication
Natroba provides a topical treatment for scabies infestations in adult and pediatric patients four years of age and older.
ParaPRO is offering Natroba (spinosad) topical suspension, 0.9% for the topical treatment of scabies infestations in adult and pediatric patients four years of age and older.
The product is an FDA-approved, targeted topical prescription therapy with multi-ectoparasitic indications.
[Read more: ParaPro obtains FDA nod for new indication of Natroba]
The company noted that the medication is the only FDA-approved, targeted topical prescription therapy that meets the latest FDA criteria for effectiveness and safety in treating scabies infestations.
Natroba is dosed as a single, full-body application.
The medication has been approved as a topical treatment of head lice infestations since 2011.